| Name | Title | Contact Details |
|---|
Whether you`re expecting a baby, dealing with a complex medical condition, or anything in between, our nonprofit hospitals and clinics have the people, technology, and experience you can trust. For nearly a century, Swedish has been the premier health-care provider in the Pacific Northwest and a trusted resource for people when it truly counts. Swedish is the largest nonprofit health care provider in the Greater Seattle Area. It is comprised of five hospital campuses (First Hill, Cherry Hill, Ballard, Edmonds and Issaquah); ambulatory care centers in Redmond and Mill Creek; and Swedish Medical Group a network of more than 183 primary care and specialty locations throughout the Great Puget Sound area. S wedish employs more than 13,000 employees and 4,200 physicians. Whether through physician clinics, health education, research and innovation or other means of outreach, we`re committed to caring for the people in our region and beyond. Swedish is proud to be an Equal Opportunity Employer. Swedish does not discriminate on the basis of race, color, gender, disability, protected veteran, military status, religion, age, creed, national origin, gender identity, sexual orientation, marital status, genetic information, or any other basis prohibited by local, state, or federal law
New Mexico Cancer Center is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
APAC Partners is a Dyer, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.
Our vision is a world where genomic information is fully accessible, understandable and integrated into health and well being. We are on a mission to help patients and healthcare providers use genetic services to improve health, lower the cost of care, and prevent disease.